BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 33194276)

  • 1. Histopathological variation in the demyelinating sentinel lesion of primary central nervous system lymphoma.
    Bajagain M; Oyoshi T; Hanada T; Higa N; Hiraki T; Kamimura K; Kuroki S; Yoshimoto K
    Surg Neurol Int; 2020; 11():342. PubMed ID: 33194276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory Demyelinating Lesions: True Sentinel Lesion or Immune-Mediated Response to Lymphoma?
    Qiu T; Chanchotisatien A; Qin Z; Wu J; Chu S
    World Neurosurg; 2021 Jan; 145():172-177. PubMed ID: 32949800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory brain lesions preceding primary central nervous system lymphoma: a case report and genetic analysis.
    XiaoHong Z; Shuo Y; GeHong D; AnChao Y; Ce W; YunYun D; Can W; SiJie H; Feng C; WenBin L
    Neurol Sci; 2023 May; 44(5):1555-1561. PubMed ID: 36599976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary central nervous system lymphoma with preceding spontaneous pseudotumoral demyelination in an immunocompetent adult patient: A case report and literature review.
    Yamamoto J; Shimajiri S; Nakano Y; Nishizawa S
    Oncol Lett; 2014 Jun; 7(6):1835-1838. PubMed ID: 24932243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demyelination preceding a diagnosis of central nervous system lymphoma.
    Kalus S; Di Muzio B; Gaillard F
    J Clin Neurosci; 2016 Feb; 24():146-8. PubMed ID: 26455545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroinflammation preceding primary central nervous system lymphoma (PCNSL) - Case reports and literature review.
    Norrington M; Rathi N; Jenkinson MD; Mills SJ
    J Clin Neurosci; 2021 Jul; 89():381-388. PubMed ID: 34083111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demyelination as a harbinger of lymphoma: a case report and review of primary central nervous system lymphoma preceded by multifocal sentinel demyelination.
    Kvarta MD; Sharma D; Castellani RJ; Morales RE; Reich SG; Kimball AS; Shin RK
    BMC Neurol; 2016 May; 16():72. PubMed ID: 27206499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory Brain Lesions as Omen of Primary Central Nervous System Lymphoma: A Case Report and Literature Review.
    Kim YJ; Kim SK; Jung TY; Kim IY; Lee KH; Moon KS
    Brain Sci; 2021 Feb; 11(2):. PubMed ID: 33557224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary Central Nervous System Lymphoma with Associated Demyelination and Creutzfeldt Astrocytes.
    Achi HE; Lally JE; Riascos RF; Zhu JJ; Tandon N; Esquenazi Y; Bhattacharjee MB; Ballester LY
    Ann Clin Lab Sci; 2018 Jul; 48(4):534-537. PubMed ID: 30143499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged interval between sentinel pseudotumoral demyelination and development of primary CNS lymphoma.
    Ng S; Butzkueven H; Kalnins R; Rowe C
    J Clin Neurosci; 2007 Nov; 14(11):1126-9. PubMed ID: 17890092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central nervous system lymphoma initially diagnosed as tumefactive multiple sclerosis after brain biopsy.
    Ohe Y; Hayashi T; Mishima K; Nishikawa R; Sasaki A; Matsuda H; Uchino A; Tanahashi N
    Intern Med; 2013; 52(4):483-8. PubMed ID: 23411706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroinflammation Preceding and Accompanying Primary Central Nervous System Lymphoma: Case Study and Literature Review.
    Lu JQ; O'Kelly C; Girgis S; Emery D; Power C; Blevins G
    World Neurosurg; 2016 Apr; 88():692.e1-692.e8. PubMed ID: 26724610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory demyelinating brain lesions heralding primary CNS lymphoma.
    Husseini L; Saleh A; Reifenberger G; Hartung HP; Kieseier BC
    Can J Neurol Sci; 2012 Jan; 39(1):6-10. PubMed ID: 22384490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroimaging and clinicopathological differences between tumefactive demyelinating lesions and sentinel lesions of primary central nervous system lymphoma.
    Sun C; Han J; Lin Y; Qi X; Li C; Liu J; Qiu F
    Front Immunol; 2022; 13():986473. PubMed ID: 36059526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Case of 55-year-old female with primary central nervous system lymphoma, presenting with brain and eye lesions and long-term relapsing/remitting course].
    Sasaki T; Nakayama T; Kitamura M; Kakuta Y; Imafuku I
    Rinsho Shinkeigaku; 2015; 55(8):567-72. PubMed ID: 26156255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B cell-rich non-neoplastic sentinel lesion preceding primary central nervous system lymphoma.
    Javier R; Shaikh N; Lesniak MS; Sonabend A; Stupp R; Behdad A; Horbinski C
    Diagn Pathol; 2018 Jun; 13(1):37. PubMed ID: 29871654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sentinel lesions of primary CNS lymphoma.
    Alderson L; Fetell MR; Sisti M; Hochberg F; Cohen M; Louis DN
    J Neurol Neurosurg Psychiatry; 1996 Jan; 60(1):102-5. PubMed ID: 8558135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gadolinium enhancement patterns of tumefactive demyelinating lesions: correlations with brain biopsy findings and pathophysiology.
    Kobayashi M; Shimizu Y; Shibata N; Uchiyama S
    J Neurol; 2014 Oct; 261(10):1902-10. PubMed ID: 25034274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary central nervous system cytotoxic T-cell lymphoma mimicking demyelinating disease.
    Kato Y; Hayashi T; Kawai-Masaoka A; Ichimura T; Sasaki A; Uchino A; Nagamine Y; Tanahashi N
    Intern Med; 2014; 53(11):1197-200. PubMed ID: 24881748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement pattern of demyelination-mimicking cerebral B-cell lymphoma.
    Ma X; Guo Z; Huang Z; Hui D; Liu Y; Jiang Y; Lu Z; Qiu W; Lu T; Qin F
    Eur J Neurol; 2022 Aug; 29(8):2499-2504. PubMed ID: 35441750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.